Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
NCT00026780 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1720
Last updated 2020-10-08
Summary
Patients who are being considered for participation in a NCI Pediatric Oncology Branch research study will be screened for eligibility under this protocol. For every NCI research study, patients must meet defined medical criteria in order to ensure the integrity of the research study and to maximize patient safety.
Tests and procedures required for determining eligibility depend on the specific study for which the patient is being considered. Some of the more common tests and procedures are:
* History and physical examination
* Blood and urine samples for routine laboratory tests and possibly research studies
* Quality of life assessment questionnaire
* Magnetic resonance imaging (MRI) scan uses a magnetic field and radio waves to produce pictures of body structures, including tumors
* Computerized tomography (CT) scan uses radiation to produce multiple detailed pictures of body structures
* X-rays uses radiation to provide a single picture of a body part
* Nuclear medicine scans uses a chemical tagged with a radioactive substance to detect tumors, measure kidney or heart function, or monitor the flow of cerebrospinal fluid (fluid that bathes the brain and spinal cord)
* Electrocardiogram (EKG) uses electrodes placed on the skin to evaluates heart rate and rhythm by measuring electrical impulses from the heart
* Echocardiogram uses high-frequency sound waves to evaluate heart structure and function
* Lumbar puncture tests for cancer cells and other substances in cerebrospinal fluid. Involves placing a needle into the lower back between the bones of the spine and withdrawing a fluid sample from the fluid-containing space below the spinal cord
* Ommaya reservoir surgically implanted catheter inserted into the fluid-filled ventricles of the brain, used to withdraw spinal fluid samples and to give medication
* Eye examination vision test and eye examination
* Biopsies removal of a small piece of tissue, by needle or by surgery, for examination under the microscope. An area of skin over the biopsy site is numbed with an anesthetic. For a needle biopsy, a needle is inserted into the tumor, tissue or bone marrow to pull out a small sample. A surgical biopsy may be done in the operating room, clinic, or hospital room, depending on the biopsy location. The tissue or tumor is removed by cutting a small piece of it with a sharp knife or scalpel and the area will be closed with sutures or staples.
Conditions
- Ewing Sarcoma
- Osteosarcoma
- Neuroblastoma
- Acute Lymphoblastic Leukemia
- Neurofibromatosis Type 1
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Brigitte C Widemann, M.D. · National Cancer Institute (NCI)
Eligibility
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-09-24
- Primary Completion
- 2020-10-07
- Completion
- 2020-10-07
Countries
- United States
Study Locations
More Related Trials
-
Two Regimens of Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Localized Ewing Sarcoma Family of Tumors
NCT00618813 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Children With Lymphoma
NCT00002590 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Dactinomycin and Vincristine in Young Patients With Cancer
NCT00674193 ·Status: COMPLETED
-
Combination Chemotherapy, Bone Marrow Transplantation, and Radiation Therapy in Treating Infants With Acute Lymphoblastic Leukemia
NCT00002785 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
NCT00002485 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
NCT00002816 ·Status: COMPLETED ·Phase: PHASE3
-
Ex Vivo Drug Sensitivity Testing and Mutation Profiling
NCT03860376 ·Status: COMPLETED
-
Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma
NCT00002618 ·Status: COMPLETED ·Phase: PHASE3
-
Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
NCT00873093 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia
NCT00003671 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor
NCT00002643 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
NCT01962103 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
High-Risk Neuroblastoma Chemotherapy Without G-CSF
NCT02786719 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy in Treating Children With Neuroblastoma
NCT00003093 ·Status: COMPLETED ·Phase: PHASE3
-
A Longitudinal Assessment of Frailty in Young Adult Survivors of Childhood Cancer
NCT02256137 ·Status: ACTIVE_NOT_RECRUITING
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Neuroblastoma
NCT00017368 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
NCT03020030 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Combination Chemotherapy in Treating Pediatric Patients With Stage III or IV Non-Hodgkin's Lymphoma
NCT00002691 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
NCT00002740 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
NCT00002941 ·Status: COMPLETED ·Phase: PHASE2
-
Insomnia Prevention in Children With Acute Lymphoblastic Leukemia
NCT05866887 ·Status: COMPLETED ·Phase: NA
-
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
NCT03126916 ·Status: RECRUITING ·Phase: PHASE3
-
Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma
NCT00057811 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer
NCT00002611 ·Status: COMPLETED ·Phase: PHASE3
-
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
NCT06172296 ·Status: RECRUITING ·Phase: PHASE3